Dermapharm Holding SE buy Maxi_Scalibusa
Summary
This prediction ended on 05.11.21 with a price of €89.65. With a performance of 184.60% the BUY prediction by Maxi_Scalibusa was a big success. A total of €1.57 was paid as dividends for this prediction. Maxi_Scalibusa has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 0.320% | 0.320% | 27.027% | 0.902% |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% | 51.111% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% | 91.988% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% | 65.852% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% | 66.636% |
Comments by Maxi_Scalibusa for this prediction
In the thread Dermapharm Holding SE diskutieren
Dermapharm
In the thread Trading Dermapharm Holding SE


